Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bcl-2-like protein 11 (BIM) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the messenger RNA encoding the pro-apoptotic protein BIM (UniProt O43521). As a BH3-only member of the BCL-2 family, BIM is a central initiator of the intrinsic apoptotic pathway, neutralizing anti-apoptotic proteins to trigger mitochondrial outer membrane permeabilization (PubMed: 22856430). The 3'UTR serves as a hub for post-transcriptional control, containing numerous binding sites for oncogenic microRNAs—such as the miR-17-92 cluster, miR-221, and miR-24—and RNA-binding proteins like DND1 that dictate mRNA stability and translation efficiency (PubMed: 23135145, 28611294). In many cancers, BIM is downregulated through the overexpression of these miRNAs, which leads to apoptosis resistance and survival of malignant cells, particularly in response to tyrosine kinase inhibitors (PubMed: 22856430). Therapeutic strategies targeting the BIM 3'UTR, including antisense oligonucleotides (ASOs) and antagomirs, aim to block miRNA-mediated repression, thereby restoring BIM expression and sensitizing tumors to programmed cell death (PubMed: 30185415).
Modulation of BIM protein levels by blocking microRNA-mediated degradation or translational inhibition to restore apoptotic sensitivity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bcl-2-like protein 11 mRNA 3' untranslated region (BIM mRNA 3'UTR).